Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
IBBQ
208
HOLDINGS
16%
ALSO IN CANC
CANC
49
HOLDINGS
67%
ALSO IN IBBQ
SECTOR DRIFT (IBBQ minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 2.4% | 2.0% | 2.0% |
 |
GILEAD SCIENCES INC | 7.2% | 1.9% | 1.9% |
|
AMGEN INC | 6.6% | 1.9% | 1.9% |
|
SUMMIT THERAPEUTICS INC | 1.4% | 2.0% | 1.4% |
|
BEIGENE LTD. SPONSORED ADR | 1.3% | 2.9% | 1.3% |
IBBQ Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 6.2% |
|
GILEAD SCIENCES INC | 5.3% |
|
ALNYLAM PHARMACEUTICALS INC | 5.3% |
|
AMGEN INC | 4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.6% |
|
INSMED INC | 2.7% |
|
BIOGEN IDEC INC | 2.1% |
|
UNITED THERAPEUTICS CORP | 1.8% |
|
INCYTE CORP | 1.6% |
IBBQ Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.0% |
|
ELI LILLY & CO | -5.0% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
 |
GENMAB A/S SPONSORED ADR | -4.5% |
|
NOVARTIS AG | -4.4% |
|
ASTRAZENECA PLC | -4.2% |
|
BRIDGEBIO PHARMA, INC. | -3.6% |
 |
MERUS N.V. | -3.5% |
|
ARCELLX, INC. | -3.3% |
|
NUVALENT, INC. CLASS A | -3.0% |